Norway’s New Health Data Sharing Platform: A Boost for Patients…
Norway has been a global frontrunner in collecting health data and building unique registries for decades but has struggled to utilise and benefit…
Tagged with Norway
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…
The Long Read / Norway: Unlocking Potential
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…
Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…
Sissel Lønning Andresen – Country Manager & Internal…
Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years, what other Pfizer affiliates can…
Photocure: Swimming in the “Blue Ocean” of Oncology…
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare success story. CEO Dan Schneider…
Norwegian Neuroscience: Nobel Prizes & Enduring Focus
Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard Moser, a married couple and the…
Norway: Ahead of the Curve on Digitalisation
Many countries have struggled to adapt to the shift to remote working and digital communication brought about by the COVID-19 pandemic and subsequent…
Daniel Malarek – General Manager, Roche Diagnostics Norway
Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19 pandemic, the Norwegian approval…
Filip Standaert – Managing Director Nordics, Johnson &…
Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe, how the affiliate responded to the…
Christian Probst – General Manager, GSK Norway
Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of bringing clinical trials back to…
Kirsti Nyhus – Market Access & External Affairs…
AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the importance of bringing clinical trials…
